GlobeNewsWire
07 Oct 2026, 01:52 UTC · 2h ago
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Impact · against what's priced in
The article contains no new material information for HIMS or HON, as it serves as a legal reminder for lawsuits already factored into current valuations. The market has already absorbed the 14.73% drop and the ongoing regulatory drag associated with these claims.
- HON+0.00
Already priced in
- The price assumes
The risk of a federal securities law investigation by Robbins Geller Rudman & Dowd LLP.





